Key Takeaways:
Arm Holdings' Q2 revenue guidance of $1.38 billion fell short of the most bullish analyst forecasts, extending a 30% selloff as investors question whether the chip designer's data center expansion can justify its 113x forward P/E.
"Demand for Arm AGI CPU, Arm's first data center chip, has exceeded expectations," Rene Haas, chief executive officer of Arm Holdings, said on the prior earnings call. The company has disclosed over $2 billion in customer demand for the AGI CPU across fiscal 2027 and 2028, with Meta as lead co-developer.
The Q2 guidance compares with Q1 revenue of about $1.26 billion, which came in line with management's forecast. Data center royalty more than doubled in the prior quarter, but R&D spending rose 43% year-over-year to $1.9 billion, compressing non-GAAP operating margin from 52.8% to 49.1%. Shares fell as much as 6.2% in pre-market trading on July 30.
The guidance miss threatens to deepen a selloff that has erased nearly a third of Arm's market value over the past month. The company's valuation — at 113x forward earnings — leaves no room for execution missteps, with the Qualcomm trial set for Q4 2026 and a 25% US semiconductor tariff adding regulatory uncertainty to the data center growth narrative.
Arm's architecture powers nearly every smartphone processor, but the growth story hinges on expanding into data centers, where it competes with Intel's x86 architecture and Nvidia's Grace CPU. The AGI CPU, its first internally designed data center chip, represents a strategic bet that could reshape its licensing model into a product-driven compute franchise. Management has cited over $2 billion in customer demand for the chip across the next two fiscal years.
The investment required to capture that opportunity is weighing on margins. R&D spending surged 43% to $1.9 billion in the latest quarter, reflecting the cost of developing the AGI CPU and expanding the Neoverse server chip lineup. Annualized contract value, a forward-looking revenue indicator, reached $1.66 billion, up 22% year-over-year.
Arm shares, which have more than doubled year-to-date despite the recent pullback, trade at a premium that leaves little room for error. The company faces two overhangs: a jury trial with Qualcomm in Q4 2026 over licensing disputes, and the potential impact of a 25% US tariff on semiconductor imports. For investors, the Q2 guidance raises the bar for the earnings call, where Haas will need to convince the market that the margin compression is temporary and the data center payoff is near.
This article is for informational purposes only and does not constitute investment advice.
